| Edward Michael Ehlers, MD | |
|
900 Seton Dr, Cumberland, MD 21502-1854 | |
| (301) 723-5030 | |
| (301) 723-6485 |
| Full Name | Edward Michael Ehlers |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 56 Years |
| Location | 900 Seton Dr, Cumberland, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104883883 | NPI | - | NPPES |
| 001668013002 | Medicaid | MD | |
| 001668013002 | Medicaid | PA | |
| 1045323 | Other | CIGNA BEHAVIORAL HEALTH | |
| 52633 | Other | HORIZON HEALTH | |
| 41311703 | Other | MD | CAREFIRST BC BS |
| 40344520 | Other | UNITED BEHAVIORAL HEALTH | |
| 63821800 | Other | MD | MAPS |
| IP14197 | Other | MD | MAGELLAN |
| 0116350000 | Medicaid | WV | |
| 33721 | Other | VALUES OPTIONS | |
| M093 0002 | Other | DC | BLUE CHOICE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | D0005139 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Western Maryland Regional Medical Center | Cumberland, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Upmc Western Maryland Health Services Llc | 7113396011 | 151 |
News Archive
State officials and health insurance providers on Tuesday promised a smooth transition into KanCare, the proposed overhaul of Kansas' $2.9 billion Medicaid program. "There is nothing simple about Medicaid," said Joe Ewert, commissioner of survey and certification with the Kansas Department for Aging and Disability Services.
Careful documentation of a hospice patient's end-of-life wishes - and prominently noting that information in health records early - could prevent unwanted hospitalizations and medical interventions, a new study suggests.
A scientist from the University of Exeter has developed a simple, cheap and highly accurate device for diagnosing a frequently fatal lung disease which attacks immune deficient individuals such as cancer patients and bone marrow transplant recipients.
A new heart-healthy, essential omega-3 fatty acid is about to improve an American pantry staple: soybean oil. The new scientific advance will move biotechnology onto the average consumer's daily radar.
OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that the company presented an update on its ZYBRESTAT ophthalmology program, including encouraging preclinical data showing that the company's topical formulation achieved target retina/choroid concentrations with minimal systemic exposure.
› Verified 2 days ago
| Entity Name | Upmc Western Maryland Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184769952 PECOS PAC ID: 7113900655 Enrollment ID: O20040608000157 |
News Archive
State officials and health insurance providers on Tuesday promised a smooth transition into KanCare, the proposed overhaul of Kansas' $2.9 billion Medicaid program. "There is nothing simple about Medicaid," said Joe Ewert, commissioner of survey and certification with the Kansas Department for Aging and Disability Services.
Careful documentation of a hospice patient's end-of-life wishes - and prominently noting that information in health records early - could prevent unwanted hospitalizations and medical interventions, a new study suggests.
A scientist from the University of Exeter has developed a simple, cheap and highly accurate device for diagnosing a frequently fatal lung disease which attacks immune deficient individuals such as cancer patients and bone marrow transplant recipients.
A new heart-healthy, essential omega-3 fatty acid is about to improve an American pantry staple: soybean oil. The new scientific advance will move biotechnology onto the average consumer's daily radar.
OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that the company presented an update on its ZYBRESTAT ophthalmology program, including encouraging preclinical data showing that the company's topical formulation achieved target retina/choroid concentrations with minimal systemic exposure.
› Verified 2 days ago
| Entity Name | Upmc Western Maryland Health Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447976584 PECOS PAC ID: 7113396011 Enrollment ID: O20221216000041 |
News Archive
State officials and health insurance providers on Tuesday promised a smooth transition into KanCare, the proposed overhaul of Kansas' $2.9 billion Medicaid program. "There is nothing simple about Medicaid," said Joe Ewert, commissioner of survey and certification with the Kansas Department for Aging and Disability Services.
Careful documentation of a hospice patient's end-of-life wishes - and prominently noting that information in health records early - could prevent unwanted hospitalizations and medical interventions, a new study suggests.
A scientist from the University of Exeter has developed a simple, cheap and highly accurate device for diagnosing a frequently fatal lung disease which attacks immune deficient individuals such as cancer patients and bone marrow transplant recipients.
A new heart-healthy, essential omega-3 fatty acid is about to improve an American pantry staple: soybean oil. The new scientific advance will move biotechnology onto the average consumer's daily radar.
OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that the company presented an update on its ZYBRESTAT ophthalmology program, including encouraging preclinical data showing that the company's topical formulation achieved target retina/choroid concentrations with minimal systemic exposure.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Edward Michael Ehlers, MD 900 Seton Dr, Cumberland, MD 21502-1854 Ph: (301) 723-5030 | Edward Michael Ehlers, MD 900 Seton Dr, Cumberland, MD 21502-1854 Ph: (301) 723-5030 |
News Archive
State officials and health insurance providers on Tuesday promised a smooth transition into KanCare, the proposed overhaul of Kansas' $2.9 billion Medicaid program. "There is nothing simple about Medicaid," said Joe Ewert, commissioner of survey and certification with the Kansas Department for Aging and Disability Services.
Careful documentation of a hospice patient's end-of-life wishes - and prominently noting that information in health records early - could prevent unwanted hospitalizations and medical interventions, a new study suggests.
A scientist from the University of Exeter has developed a simple, cheap and highly accurate device for diagnosing a frequently fatal lung disease which attacks immune deficient individuals such as cancer patients and bone marrow transplant recipients.
A new heart-healthy, essential omega-3 fatty acid is about to improve an American pantry staple: soybean oil. The new scientific advance will move biotechnology onto the average consumer's daily radar.
OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that the company presented an update on its ZYBRESTAT ophthalmology program, including encouraging preclinical data showing that the company's topical formulation achieved target retina/choroid concentrations with minimal systemic exposure.
› Verified 2 days ago
Saiqa Choudhry, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 625 Kent Ave Ste 302, Cumberland, MD 21502 Phone: 301-777-1930 Fax: 301-777-8470 | |
Dr. Nirmalam Nagulendran, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 12500 Willowbrook Rd, Cumberland, MD 21502 Phone: 301-777-5627 Fax: 301-777-5630 | |
Dr. Jeremy Alan Herschler, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 12500 Willowbrook Rd Se, Cumberland, MD 21501 Phone: 301-759-5280 | |
Samuel Navaratnam Nava, M.D. Psychiatry & Neurology Medicare: May Accept Medicare Assignments Practice Location: 81 Baltimore St, Suite 216, Cumberland, MD 21502 Phone: 301-777-9330 | |
Stephen Schellhase, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 915 Bishop Walsh Rd, Cumberland, MD 21502 Phone: 301-724-7277 Fax: 301-724-7022 | |
Steven F Kendell, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 12502 Willowbrook Rd Ste 380, Cumberland, MD 21502 Phone: 240-964-8585 Fax: 240-964-8586 |